Standout Papers

Pirfenidone in idiopathic pulmonary fibrosis 2009 2026 2014 2020 666
  1. Pirfenidone in idiopathic pulmonary fibrosis (2009)
    Masahito Ebina, Yasuhiro Kondoh et al. European Respiratory Journal
  2. Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002) (2012)
    Akira Inoue, Kunihiko Kobayashi et al. Annals of Oncology

Immediate Impact

8 by Nobel laureates 24 from Science/Nature 75 standout
Sub-graph 1 of 20

Citing Papers

Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
2022 Standout
Fibrosis: from mechanisms to medicines
2020 StandoutNature
6 intermediate papers

Works of T. Nukiwa being referenced

Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)
2012 Standout
Pirfenidone in idiopathic pulmonary fibrosis
2009 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
T. Nukiwa 2058 1148 1030 74 3.7k
Kathryn A. Wikenheiser‐Brokamp 1158 678 1342 82 3.1k
R G Crystal 965 530 1247 43 3.3k
James S. Hagood 2735 715 1888 97 5.5k
Oichi Kawanami 2020 477 1055 96 4.3k
Paavo Pääkkö 2109 1730 2446 148 6.1k
Jeffrey C. Horowitz 2562 563 1811 79 5.6k
C. Lafuma 929 405 705 73 2.8k
Roger Stenling 1153 1751 1317 110 4.3k
Calvin Vary 762 683 2379 124 4.4k
Renate Kain 1385 880 2598 116 5.3k

All Works

Loading papers...

Rankless by CCL
2026